Lifecore Biomedical, Inc. · NASDAQ:LFCR
BlackRock, Inc. reported a 5.40% stake in Lifecore Biomedical, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 5.40% stake in Lifecore Biomedical, Inc., 2,010,546 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 2,010,546
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.40% | 2,010,546 |
Source
Related
- Lifecore Biomedical, Inc.
- BlackRock, Inc.
- Lifecore Biomedical, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Schedule 13D/A · Nelson Obus · Sep 29, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Sep 28, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Jul 2, 2026
- Schedule 13D/A · 22NW Fund, LP · Jul 2, 2026
- Form 4 · Legion Partners, L.P. I · Jun 8, 2026